CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 99 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $643,897 | -7.6% | 55,081 | +6.3% | 0.00% | 0.0% |
Q2 2023 | $696,622 | -20.6% | 51,832 | -2.0% | 0.00% | -33.3% |
Q1 2023 | $876,817 | -10.4% | 52,884 | +0.5% | 0.01% | -14.3% |
Q4 2022 | $979,085 | +45.7% | 52,639 | +0.5% | 0.01% | +40.0% |
Q3 2022 | $672,000 | +114.0% | 52,394 | +16.8% | 0.01% | +150.0% |
Q2 2022 | $314,000 | -21.5% | 44,846 | -7.0% | 0.00% | 0.0% |
Q1 2022 | $400,000 | +14.6% | 48,208 | -6.6% | 0.00% | 0.0% |
Q4 2021 | $349,000 | +23.8% | 51,602 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $282,000 | -9.9% | 53,145 | -2.3% | 0.00% | +100.0% |
Q2 2021 | $313,000 | +19.9% | 54,409 | -3.8% | 0.00% | 0.0% |
Q1 2021 | $261,000 | +38.8% | 56,570 | +0.3% | 0.00% | 0.0% |
Q4 2020 | $188,000 | +9.3% | 56,420 | -2.8% | 0.00% | 0.0% |
Q3 2020 | $172,000 | -37.2% | 58,039 | -2.2% | 0.00% | 0.0% |
Q2 2020 | $274,000 | +24.5% | 59,358 | +3.9% | 0.00% | 0.0% |
Q1 2020 | $220,000 | -3.1% | 57,105 | -5.5% | 0.00% | 0.0% |
Q4 2019 | $227,000 | -29.7% | 60,405 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $323,000 | +36.9% | 60,912 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $236,000 | -24.8% | 61,337 | -0.3% | 0.00% | 0.0% |
Q1 2019 | $314,000 | +157.4% | 61,509 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $122,000 | -49.6% | 63,503 | -0.8% | 0.00% | 0.0% |
Q3 2018 | $242,000 | +23.5% | 63,991 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $196,000 | +46.3% | 62,838 | +12.3% | 0.00% | – |
Q1 2018 | $134,000 | -28.7% | 55,935 | +16.1% | 0.00% | -100.0% |
Q4 2017 | $188,000 | +55.4% | 48,193 | +0.5% | 0.00% | – |
Q3 2017 | $121,000 | -0.8% | 47,965 | +8.1% | 0.00% | – |
Q2 2017 | $122,000 | -99.8% | 44,379 | +0.6% | 0.00% | – |
Q1 2016 | $52,000,000 | -51.9% | 44,119 | 0.0% | 0.00% | – |
Q4 2015 | $108,000,000 | +81103.0% | 44,119 | -0.2% | 0.00% | -100.0% |
Q3 2015 | $133,000 | -99.9% | 44,196 | +0.1% | 0.00% | 0.0% |
Q2 2015 | $182,315,000 | +3503.1% | 44,144 | +2107.2% | 0.00% | – |
Q2 2014 | $5,060,000 | +11.9% | 2,000 | 0.0% | 0.00% | – |
Q1 2014 | $4,520,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |